This Article Free upon publication Full Text Full Text (PDF) Correction (v29,p1242) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Taubman, M. B. Search for Related Content PubMed Articles by Taubman, M. B.

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2009;29:613.)
© 2009 American Heart Association, Inc.

Editorials

Recipients of the 2009 New Investigator Awards

Mark B. Taubman

An extract of the first 250 words of the full text is provided, because this article has no abstract.

This is the fourth year of competition for ATVB New Investigator Awards. The Awards recognize articles published in ATVB in 2008 that were submitted by new investigators and judged to be the most outstanding in the Atherosclerosis and Lipoproteins, Thrombosis, and Vascular Biology sections of the journal. The three awards are named for Dr Daniel Steinberg, who devised a method to determine the site of degradation of the proteins and lipids of a lipoprotein, which led to the concept of selective uptake of cholesterol and apoprotein that characterizes the reverse cholesterol transport pathway; Dr Karl Link, who identified dicoumarol as the hemorrhagic factor in spoiled sweet clover hay, and then developed dicoumarol and warfarin as anticoagulant drugs; and Dr Werner Risau, who formulated key concepts for the regulation of angiogenesis, challenged the prevailing dogmas about angiogenic factors, and proposed the now accepted hypothesis that several growth factors act sequentially to mediate vasculogenesis, angiogenesis, and vascular remodeling.

In the fourth year of the award, 650 papers were submitted for the Awards. Recipients of the awards are:

Owen McCarty, PhD, Oregon Health & Science University, the 2009 recipient of the Karl Link New Investigator Award in Thrombosis, for his article "The Thrombin Mutant W215A/E217A Acts As A Platelet GPIb Antagonist" (Arterioscler Thromb Vasc Biol. 2008;28:329–334).

View larger version (134K):   Owen McCarty, PhD

José WA van der Hoorn, PhD, TNO BioSciences/LUMC, the 2009 recipient of the Daniel Steinberg New Investigator Award in Atherosclerosis/Lipoproteins, for her article "Niacin Increases HDL by Reducing Hepatic Expression and Plasma . . . [Full Text of this Article]